Members

Antibiotic Resistance and Pathogenicity of Bacterial Infections members:

ANTONIO OLIVER, PhD (Research Group Coordinator, PI Resistance mechanisms and epidemiology)
CARLOS JUAN, PhD (Senior Researcher, PI Cell-wall biology)
BARTOLOMÉ MOYA, PhD (Senior Researcher, PI Experimental therapeutics)
SEBASTIAN ALBERTÍ, PhD (Senior Researcher, PI Host-pathogen interactions)
MARÍA DOLORES MACIÀ, PhD (Senior Researcher, PI Biofilms)
ANA MENA, PhD (Senior Researcher, PI C. difficile infections)
JOSE IGNACIO AYESTARAN
ISABEL MARIA BARCELÓ
GABRIEL CABOT, PhD
ASUNCIÓN COLOMAR
SARA CORTÉS-LARA
ESTER DEL BARRIO-TOFIÑO
ANTONIO DOMENECH-SÁNCHEZ, PhD
MARIA ESCOBAR-SALOM
MIGUEL ÁNGEL ESTÉVEZ
ALMUDENA FERNÁNDEZ-MUÑOZ
PABLO ARTURO FRAILE-RIBOT
MARIA ANTÒNIA GOMIS-FONT
ALEXANDRE GONZÁLEZ
ELENA JORDANA-LLUCH, PhD
SILVIA DAIANA LÓPEZ-ARGÜELLO, PhD
CARLA LÓPEZ-CAUSAPÉ, PhD
MARGALIDA MATEU
MARÍA DEL DULCE MONTANER
XAVIER MULET, PhD
ESTRELLA ROJO-MOLINERO, PhD
ENRIQUE RUIZ DE GOPEGUI, PhD
IRINA SÁNCHEZ-DIENNER, PhD
MIQUEL ÀNGEL SASTRE-FEMENIA
LORETO SUÁREZ
GABRIEL TALTAVULL
GABRIEL TORRENS, PhD
LAURA ZAMORANO, PhD

Main research lines:

• Molecular mechanisms and epidemiology of antimicrobial resistance.
• In vitro and in vivo evolution of resistance
• Analysis of the resistome and virulome through whole genome sequencing
• Peptidoglycan recycling and regulation of AmpC expression
• Cell-wall biology
• Host-pathogen interactions
• Interplay between resistance and virulence
• Epidemiology and pathogenesis of chronic bacterial infections
• Bacterial adaptation mechanisms and role of hypermutation
• In vitro and in vivo experimental therapeutics
• Bacterial biofilms

Our research lines are mainly based on Pseudomonas aeruginosa as model organism, but also include other Gram negative pathogens such as Enterobacterales or Acinetobacter baumannii and some Gram positives such as Staphylococcus spp. or Clostridioides difficile